Search - tctmd.com

Displaying 561 - 580 of 1012

Sort: Relevancy | Date

Presentation TCT 2016

Severe AS and LV Dysfunction

Presenter: Howard C. Herrmann, Vinod H. Thourani, G. Michael Deeb

October 31, 2016

Presentation TCT 2016

Evolution of Durable PolymerBased DES: Pathologic Perspectives on Design, Safety, and Efficacy

Presenter: Donald Cutlip, Christian Hengstenberg, Michael Joner

October 31, 2016

Presentation TCT 2016

Rationale for and Design of TWILIGHT and GLOBAL LEADERS: What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Jorge Gaspar, C. Michael Gibson

October 30, 2016

Presentation TCT 2016

Management of Visceral Artery Aneurysms: When to Intervene and How to Do It

Presenter: Gary M. Ansel, Michael R. Jaff, Constantino S. Pena

October 30, 2016

Presentation TCT 2016

Future Therapy for Symptomatic HCM Patients With and Without Dynamic Obstruction

Presenter: George S. Hanzel, Antoine Lafont, Michael A. Fifer

October 30, 2016

Presentation TCT 2016

Great Debate 1: The Optimal Management of Chronic Mesenteric Ischemia Is Catheter-based Intervention!

Presenter: Gary M. Ansel, Michael R. Jaff, Herbert D. Aronow

October 30, 2016

Presentation TCT 2016

Debate: Surgery, Septal Ablation or Medical Therapy for Obstructive HCM Not so Fast: Try Optimizing Medical Therapy First!

Presenter: George S. Hanzel, Antoine Lafont, Michael A. Fifer

October 30, 2016

Presentation TCT 2016

Role of Papillary Muscle Relocation in Ischemic Mitral Valve Regurgitation

Presenter: Michael J. Mack, Francesco Maisano, Marco Moscarelli

October 30, 2016

Presentation TCT 2016

How Good Can Surgical Outcomes Be in Secondary MR?

Presenter: Michael J. Mack, Francesco Maisano, Michael Argenziano

October 30, 2016

Presentation TCT 2016

Applying Lessons From the CTSN to Clinical Practice

Presenter: Michael J. Mack, Francesco Maisano

October 30, 2016

Presentation TCT 2016

Minimally Invasive and Robotic Repair for Primary MR: Less Invasive With Great Outcomes?

Presenter: Michael J. Mack, Francesco Maisano, Robert L. Smith

October 30, 2016

Presentation TCT 2016

Treatment of Renal Artery Fibromuscalar Dysplasia: Indications, Techniques, and Outcomes

Presenter: Gary M. Ansel, Michael R. Jaff, Mehdi H. Shishehbor

October 30, 2016

Presentation TCT 2016

Surgical Outcomes in Primary MR: Results From Expert Surgeons vs Real Life Surgeons

Presenter: Michael J. Mack, Francesco Maisano, Patrick M. McCarthy

October 30, 2016

Presentation TCT 2016

Low-Risk Studies: Design and Updates II - The PARTNER 3 Low-Risk Trial

Presenter: Patrick T. O'Gara, Alec S. Vahanian, Michael J. Mack

October 30, 2016

Presentation TCT 2016

Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro Pacing

Presenter: Bernard J. Gersh, Harry Rakowski, Michael A. Fifer

October 30, 2016

Presentation TCT 2016

Hypertension Treatment Targets Beyond the Kidneys

Presenter: Felix Mahfoud, Michael A. Weber, Atul Pathak

October 30, 2016

Presentation TCT 2016

Do the Benefits of Bivalirudin Translate to Radial Intervention? Evidence From Randomized Trials

Presenter: A. Michael Lincoff, Franz-Josef Neumann, John A. Bittl

October 30, 2016

Presentation TCT 2016

The Renal Nerves and Their Role in Hypertension: An Updated Synthesis (Anatomy and Pathophysiology)

Presenter: Felix Mahfoud, Michael A. Weber, Michael Joner

October 30, 2016

Presentation TCT 2016

Should Bivalirudin Only Be Used With a Prolonged Post-PCI Infusion?

Presenter: A. Michael Lincoff, Franz-Josef Neumann, Gregg W. Stone

October 30, 2016

Presentation TCT 2016

Start With a Three-way Debate: Bivalirudin Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Presenter: A. Michael Lincoff, Franz-Josef Neumann, Harvey D. White

October 30, 2016

Advertisement

Severe AS and LV Dysfunction

Evolution of Durable PolymerBased DES: Pathologic Perspectives on Design, Safety, and Efficacy

Rationale for and Design of TWILIGHT and GLOBAL LEADERS: What I Expect the Findings to Be But What Wont Surprise Me!

Management of Visceral Artery Aneurysms: When to Intervene and How to Do It

Future Therapy for Symptomatic HCM Patients With and Without Dynamic Obstruction

Great Debate 1: The Optimal Management of Chronic Mesenteric Ischemia Is Catheter-based Intervention!

Debate: Surgery, Septal Ablation or Medical Therapy for Obstructive HCM Not so Fast: Try Optimizing Medical Therapy First!

Role of Papillary Muscle Relocation in Ischemic Mitral Valve Regurgitation

How Good Can Surgical Outcomes Be in Secondary MR?

Applying Lessons From the CTSN to Clinical Practice

Minimally Invasive and Robotic Repair for Primary MR: Less Invasive With Great Outcomes?

Treatment of Renal Artery Fibromuscalar Dysplasia: Indications, Techniques, and Outcomes

Surgical Outcomes in Primary MR: Results From Expert Surgeons vs Real Life Surgeons

Low-Risk Studies: Design and Updates II - The PARTNER 3 Low-Risk Trial

Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro Pacing

Hypertension Treatment Targets Beyond the Kidneys

Do the Benefits of Bivalirudin Translate to Radial Intervention? Evidence From Randomized Trials

The Renal Nerves and Their Role in Hypertension: An Updated Synthesis (Anatomy and Pathophysiology)

Should Bivalirudin Only Be Used With a Prolonged Post-PCI Infusion?

Start With a Three-way Debate: Bivalirudin Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content